The hemopexin domain of matrix metalloproteinase-9 activates cell signaling and promotes migration of schwann cells by binding to low-density lipoprotein receptor …

E Mantuano, G Inoue, X Li, K Takahashi… - Journal of …, 2008 - Soc Neuroscience
E Mantuano, G Inoue, X Li, K Takahashi, A Gaultier, SL Gonias, WM Campana
Journal of Neuroscience, 2008Soc Neuroscience
Low-density lipoprotein receptor-related protein (LRP-1) is an endocytic receptor for diverse
proteins, including matrix metalloproteinase-9 (MMP-9), and a cell-signaling receptor. In the
peripheral nervous system (PNS), LRP-1 is robustly expressed by Schwann cells only after
injury. Herein, we demonstrate that MMP-9 activates extracellular-signal-regulated kinase
(ERK1/2) and Akt in Schwann cells in culture. MMP-9 also promotes Schwann cell migration.
These activities require LRP-1. MMP-9-induced cell signaling and migration were blocked …
Low-density lipoprotein receptor-related protein (LRP-1) is an endocytic receptor for diverse proteins, including matrix metalloproteinase-9 (MMP-9), and a cell-signaling receptor. In the peripheral nervous system (PNS), LRP-1 is robustly expressed by Schwann cells only after injury. Herein, we demonstrate that MMP-9 activates extracellular-signal-regulated kinase (ERK1/2) and Akt in Schwann cells in culture. MMP-9 also promotes Schwann cell migration. These activities require LRP-1. MMP-9-induced cell signaling and migration were blocked by inhibiting MMP-9-binding to LRP-1 with receptor-associated protein (RAP) or by LRP-1 gene silencing. The effects of MMP-9 on Schwann cell migration also were inhibited by blocking the cell-signaling response. An antibody targeting the hemopexin domain of MMP-9, which mediates the interaction with LRP-1, blocked MMP-9-induced cell signaling and migration. Furthermore, a novel glutathione-S-transferase fusion protein (MMP-9-PEX), which includes only the hemopexin domain of MMP-9, replicated the activities of intact MMP-9, activating Schwann cell signaling and migration by an LRP-1-dependent pathway. Constitutively active MEK1 promoted Schwann cell migration; in these cells, MMP-9-PEX had no further effect, indicating that ERK1/2 activation is sufficient to explain the effects of MMP-9-PEX on Schwann cell migration. Injection of MMP-9-PEX into sciatic nerves, 24 h after crush injury, robustly increased phosphorylation of ERK1/2 and Akt. This response was inhibited by RAP. MMP-9-PEX failed to activate cell signaling in uninjured nerves, consistent with the observation that Schwann cells express LRP-1 at significant levels only after nerve injury. These results establish LRP-1 as a cell-signaling receptor for MMP-9, which may be significant in regulating Schwann cell migration and physiology in PNS injury.
Soc Neuroscience